Ovid Therapeutics Inc. (OVID) NASDAQ
2.68
+0.02(+0.75%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.68
+0.02(+0.75%)
Currency In USD
| Market Cap | 120.19M |
| Enterprise Value | 120.46M |
| P/E Ratio | -12.57 |
| PEG Ratio | 0.56 |
| Price/Sales Ratio | 55.81 |
| Price/Book Ratio | 1.68 |
| Enterprise/Revenue | 55.85 |
| Enterprise/EBITDA | -9.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2.4 |
| Operating Margin | -5.85 |
| Return On Assets | -0.12 |
| Return On Equity | -0.24 |
| Revenue | 7.25M |
| Revenue/Share | 0.09 |
| Gross Profit | 6.95M |
| EBITDA | -42.14M |
| Net Income | -17.41M |
| Diluted EPS | -0.24 |
| Total Cash | 69.64M |
| Total Cash/Share | 0.85 |
| Total Debt | 13.42M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 10.91 |
| Book Value Per Share | 1.6 |
| 52-Week Change | 724.62 |
| 52-Week High | 3.11 |
| 52-Week Low | 0.27 |
| Moving Average 50 Days | 2.13 |
| Moving Average 200 Days | 1.51 |
| Average Volume | 3.11M |
| Shares Outstanding | 151.03M |
| % Held by Institutions | 87.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |